Positive indication means upadacitinib will be available to those with previously treated severe active RA*
SMC approval is based on data from pivotal Ph... Read More...
Healthcare Professional ONLY
This website is intended for Healthcare professionals only
Are you a qualified pharmacist or health professional?
By continuing to access this site, you are consenting to viewing promotional product information provided by our pharmaceutical company sponsors
